Community Health Systems Inc (CYH) stock analysis
Close on Nov 12, 2026Market cap $311.67MP/E 8.5Yield –
StockData Score
Prices as of Nov 12, 2026How the score works
Weak8 of 30 checks passed
Community Health Systems passes 8 of the 30 checks behind our score; 13 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 3/6
- Growth
- 2/6
- Past performance
- 2/6
- Financial health
- 1/6
- Dividend
- 0/6
What stands out
EPS growing 10%+ a year
Diluted EPS grew 121% a year over the last three fiscal years.
P/E below the industry
Community Health Systems's P/E of 8.5 is below the Health Services median of 23.9.
EV/EBITDA below its 5-year median
Community Health Systems's EV/EBITDA of 5.8 is below its 5-year median of 8.3.
P/S below the industry
Community Health Systems's price-to-sales of 0.03 is below the Health Services median of 1.03 (book value is negative, so we use sales).
What to watch
Return on capital under 10%
Return on invested capital was 7.5%, below the 10% that usually covers the cost of capital.
Earnings shrank over 5 years
Net income shrank 0.1% a year on average over the last five fiscal years.
Revenue growing under 10% a year
Revenue grew 0.7% a year over the last three fiscal years, short of the 10% we look for.
Earnings growth not accelerating
Net income grew -89.1% over the last twelve months, against a 5-year average of -0.1% a year.
Valuation3/6
P/E against its history
Not enough price and earnings history to compare.
P/E below the industry
Community Health Systems's P/E of 8.5 is below the Health Services median of 23.9.
EV/EBITDA below its 5-year median
Community Health Systems's EV/EBITDA of 5.8 is below its 5-year median of 8.3.
P/S below the industry
Community Health Systems's price-to-sales of 0.03 is below the Health Services median of 1.03 (book value is negative, so we use sales).
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.
Growth2/6
Revenue growing under 10% a year
Revenue grew 0.7% a year over the last three fiscal years, short of the 10% we look for.
EPS growing 10%+ a year
Diluted EPS grew 121% a year over the last three fiscal years.
Earnings growth not accelerating
Net income grew -89.1% over the last twelve months, against a 5-year average of -0.1% a year.
Growing slower than the industry
Revenue grew -7.8% over the last twelve months; the Health Services median is 4.0%.
Guidance lowered
Community Health Systems lowered its 2026 Adjusted EBITDA outlook on Jul 22, 2026.
Gross margin improving
Gross margin was 85.5% over the last twelve months, against 84.8% a year earlier.
Past performance2/6
Return on equity
Needs positive equity and five years of results.
Return on capital under 10%
Return on invested capital was 7.5%, below the 10% that usually covers the cost of capital.
Return on equity against the industry
Needs positive equity.
Earnings shrank over 5 years
Net income shrank 0.1% a year on average over the last five fiscal years.
Net margin above its 5-year average
Net margin was 0.3% over the last twelve months, against a 5-year average of 0.2%.
Net margin above the industry
Community Health Systems's net margin of 0.3% is above the Health Services median of -2.6%.
Financial health1/6
Debt level
Needs debt and equity figures.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt not well covered by cash flow
Operating cash flow over the last twelve months equals 2.2% of total debt; we look for at least 20%.
Interest coverage
Interest expense is not reported separately.
Short-term assets cover short-term debts
Current assets are 1.48 times current liabilities.
Elevated bankruptcy risk
The Altman Z-score is 1.00; above 3 is the safe zone and below 1.8 the distress zone.
Dividend0/6
No dividend
Community Health Systems has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itWe don't publish a fair value for Community Health Systems. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Health Services median 23.9
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Medium risk
- Average value traded per day
- $4.80M
- Value traded per 1% price move
- $1.74M
Downside
Medium risk
- Typical loss in a bad month
- 23.8%
- Volatility (annualized)
- 54%
- Sharpe ratio, 1 year
- -0.75
- Beta to the S&P 500 (5Y)
- 1.72
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -1.2% | +0.7% | +1.2% | – | |
| Gross profit | -0.6% | +1.2% | +1.6% | – | |
| Operating income | +174.5% | +21.9% | +5.7% | +1.1% | |
| Net income | – | +122.8% | -0.1% | +12.4% | |
| EPS, diluted | – | +120.8% | -3.0% | +10.7% | |
| Free cash flow | +73.3% | – | -34.6% | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | -61.1% | -26.6% | -30.8% | |
| Return on assets | -7.1% | 3.2% | 3.7% | |
| Current ratio | 1.62 | 1.60 | 1.46 | |
| Debt to equity | 9.44 | -7.52 | -7.46 | |
| Net debt to EBITDA | 62.52× | 6.26× | 5.30× | |
| Capex to revenue | 4.0% | 3.7% | 2.7% | |
| Diluted shares | 111M | 117M | 135M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Community Health Systems generated $1.66B from operations and spent $2.05B on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 4.1% | 0.92× | -8.24× | -30.8% |
| FY2024 | -4.1% | 0.89× | -8.62× | 31.2% |
| FY2023 | -1.1% | 0.86× | -10.56× | 9.6% |
| FY2022 | 0.4% | 0.82× | -10.91× | -3.4% |
| FY2021 | 1.9% | 0.79× | -10.42× | -15.3% |
| FY2020 | 4.3% | 0.75× | -8.23× | -26.6% |
| FY2019 | -5.1% | 0.84× | -8.38× | 36.0% |
| FY2018 | -5.6% | 0.85× | -14.47× | 68.5% |
| FY2017 | -16.0% | 0.78× | 46.46× | -580.0% |
| FY2016 | -9.3% | 0.76× | 8.62× | -61.1% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$509.00M
- Cash generatingOperating cash flow above zero$543.00M
- Return on assets improvedROA up on the prior year-3.6% → 3.6%
- Earnings backed by cashOperating cash flow above net income$543.00M vs $509.00M
- Less leverageLong-term debt to assets fell81.3% → 78.6%
- Better liquidityCurrent ratio rose1.41 → 1.46
- No dilutionShare count did not rise132M → 135M
- Gross margin improvedGross margin up on the prior year84.60% → 85.07%
- More efficientAsset turnover rose0.87 → 0.89
See a number that looks wrong?